American Century Companies’s Century Therapeutics IPSC Stock Holding History

American Century Companies’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$133K	Buy	+58,742	New	+$124K	﹤0.01%	2756

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

American Century Companies's IPSC Position: Q1 2026 in Review

American Century Companies opened a new position in Century Therapeutics (IPSC) in Q1 2026: 58,742 shares worth $133K. The stake represents ﹤0.01% of the portfolio and ranks #2756 among its holdings.

72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

American Century Companies held 58,742 shares of Century Therapeutics worth $133K as of Q1 2026.
Century Therapeutics was a new American Century Companies position in Q1 2026.
Century Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2756 holding.
72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.